europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

EuropaBio launches a new Biopharmaceutical Strategy Group

03/05/2021
NEWS RELEASE

EuropaBio launches a new Biopharmaceutical Strategy Group

Brussels, 3 May 2021 – 8 April 2021, the EuropaBio Healthcare Council has decided to create a Biopharmaceutical Strategy Group (BSG). BSG will serve as a forum for members to routinely engage in the revision of the general pharmaceutical legislation..

For the upcoming two years, the BSG group members will develop content and policy recommendations and will carry out the necessary advocacy activities.

Among others, the BSG will be in charge of:

1) promoting incentives for the biotechnology industry that create the right conditions to attract investors and to support long term investment in high risk R&D;

2) working on proposals aiming at improving implementation of existing EU legislation through legislative and non-legislative instruments;

3) fostering an innovation-enabling regulation in the EU;

4) developing contributions to develop an industrial strategy for healthcare biotechnology focused on innovations such as advanced manufacturing;

5) explaining what is needed for the biotechnology ecosystem to work and ensure its global competitiveness.

The members of the BSG consist of regulatory and policy experts, they have been selected to ensure the broadest membership representation and the right level of expertise needed for EuropaBio’s contributions to the Pharmaceutical Strategy. The group will be Chaired by Philip Schwab (AbbVie) and Thomas Bols (PTC Therapeutics) Vice-Chair.

The first BSG meeting will take place in mid-May, online.

The Biopharmaceutical Strategy is one of the key priorities of EuropaBio in the upcoming years. On 27 April 2021 EuropaBio sent its response to the EU evaluation and revision of the general pharmaceutical legislation calling for a creation of a future-proof and patient-oriented and leading biotechnology sector in the EU.

Download
Biopharmaceutical-group_news-releaseDownload

Share
Alexandra Simionca
Alexandra Simionca

Related posts

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more
16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins


Read more
19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe


Read more
19/12/2022

The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry


Read more

Important links

  • EuropaBio launches SME BioForum in Rare Diseases
  • EuropaBio launches Industry Advisory Group for new Biomanufacturing Platform

Categories in our Newsroom

Search by tags

  • Innovation
  • Excellence
  • Science
  • ATMPs
  • Healthcare Biotech
  • Industrial Biotech
  • Investment
  • EuropaBio
  • EFIB
  • Regulation
  • Rare Diseases
  • COVID-19
  • Members
  • Cancer
  • Patients
  • Patient BioForum
  • Gene & Cell Therapies
  • Accessibility
  • Intellectual Property
  • Pharmaceutical Strategy for Europe

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies